Saamir A. Hassan, M.D.

Peer-Reviewed Articles

1. AAgha, AZarifa, PKim, CIliescu, GGladish, SHassan, NPalaskas, JBDurand, YLu, JLopez. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. METHODIST DEBAKEY CARDIOVASC J:266, 2019.
2. Hassan SA, Palaskas NL, Agha AM, Iliescu C, Lopez-Mattei J, Chen C, Zheng H, Yusuf SW. Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep 21(11):140, 2019. e-Pub 2019. PMID: 31745664.
3. Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol 19(4):382-387, 2019. e-Pub 2018. PMID: 30543051.
4. Kitkungvan D, Kalluru D, Lunagariya A, Sanchez L, Yusuf SW, Hassan S, Palaskas N, Mouhayar E, Banchs J. Safety of Transesophageal Echocardiography in Patients with Thrombocytopenia. J Am Soc Echocardiogr 32(8):1010-1015, 2019. e-Pub 2019. PMID: 31239084.
5. Balanescu SM, Balanescu DV, Donisan T, Yang EH, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Cilingiroglu M, Marmagkiolis K, Kar B, Iliescu C. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?. Curr Cardiol Rep 21(8):83, 2019. e-Pub 2019. PMID: 31286273.
6. Balanescu DV, Donisan T, Lopez-Mattei J, Hassan S, Kim P, Dasari A, Halperin D, Yao J, Kar B, Gregoric I, Balanescu SM, Iliescu C. The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment. Oncol Lett 17(5):4126-4132, 2019. e-Pub 2018. PMID: 30944605.
7. Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol 123(8):1351-1357, 2019. e-Pub 2019. PMID: 30765065.
8. Ghotra AS, Thompson K, Lopez-Mattei J, Bawa D, Hernandez R, Banchs J, Palaskas N, Iliescu C, Kim P, Yusuf SW, Hassan SA. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography 36(2):229-236, 2019. e-Pub 2018. PMID: 30569522.
9. Agha AM, Lopez-Mattei J, Donisan T, Balanescu D, Iliescu CA, Banchs J, Kim PY, Palaskas NL, Yusuf S, Gladish G, Hassan S. Multimodality imaging in carcinoid heart disease. Open Heart 6(1):e001060, 2019. e-Pub 2019. PMID: 31245014.
10. Zarifa A, Salih M, Lopez-Mattei J, Lee H, Iliescu C, Hassan S, Palaskas N, Durand JB, Mouhayar E, Kim J, Kim P. Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but serious adverse event. JIPO 1(2):68-77, 2018.
11. Kitkungvan D, Yusuf SW, Moudgil R, Palaskas N, Guindani M, Juhee S, Hassan S, Sanchez L, Banchs J. Echocardiographic measures associated with the presence of left ventricular thrombus in patients with chemotherapy-related cardiac dysfunction. Echocardiography 35(10):1512-1518, 2018. e-Pub 2018. PMID: 30005128.
12. Moudgil R, Hassan S, Palaskas N, Lopez-Mattei J, Banchs J, Yusuf SW. Evolution of echocardiography in subclinical detection of cancer therapy-related cardiac dysfunction. Echocardiography 35(6):860-868, 2018. e-Pub 2018. PMID: 29749652.
13. Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, Kim P, Durand JB, Lopez-Mattei JC. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med 20(4):29, 2018. e-Pub 2018. PMID: 29556752.
14. Hassan SA, Palaskas N, Kim P, Iliescu C, Lopez-Mattei J, Mouhayar E, Mougdil R, Thompson K, Banchs J, Yusuf SW. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep 20(2):10, 2018. e-Pub 2018. PMID: 29423705.
15. Liu VY, Agha AM, Lopez-Mattei J, Palaskas N, Kim P, Thompson K, Mouhayar E, Marmagkiolis K, Hassan SA, Karimzad K, Iliescu CA. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med 5(48):48, 2018. e-Pub 2018. PMID: 29868614.
16. Agha AM, Parwani P, Guha A, Durand JB, Iliescu CA, Hassan S, Palaskas NL, Gladish G, Kim PY, Lopez-Mattei J. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 5(2):e000881, 2018. e-Pub 2018. PMID: 30305910.
17. Giza DE, Lopez-Mattei J, Vejpongsa P, Munoz E, Iliescu G, Kitkungvan D, Hassan SA, Kim P, Ewer MS, Iliescu C. Stress-Induced Cardiomyopathy in Cancer Patients. Am J Cardiol 120(12):2284-2288, 2017. e-Pub 2017. PMID: 29096885.
18. Hassan SA, Banchs J, Iliescu C, Dasari A, Lopez-Mattei J, Yusuf SW. Carcinoid Heart Disease. Heart 103(19):1488-1495, 2017. e-Pub 2017. PMID: 28596302.
19. Lopez-Mattei J, Iliescu C, Durand JB, Hassan S, Kim P, Sierra-Galan L, Gladish G. The role of cardiac MRI in cardio-oncology. Future Cardiol 13(4):311-316, 2017. e-Pub 2017. PMID: 28639454.
20. Giza DE, Iliescu G, Hassan S, Marmagkiolis K, Iliescu C. Cancer as a Risk Factor for Cardiovascular Disease. Curr Oncol Rep 19(39):39, 2017. PMID: 28421481.
21. Raghunathan D, Khilji MI, Hassan SA, Yusuf SW. Radiation-Induced Cardiovascular Disease. Curr Atheroscler Rep 19(22):22, 2017. PMID: 28315200.
22. Hassan SA, Yusuf SW, Sharma J, Khan J, Guindani M, Valero V, Chavez-McGregor M, Banchs J. Predictors of left ventricular systolic function recovery in the setting of sinus tachycardia in patients with cancer. Echocardiography 34(1):29-36, 2017. e-Pub 2016. PMID: 27767228.
23. Hassan SA, Lopez-Mattei J, Sanchez L, Banchs J. Improved Reliability in Left Ventricular Ejection Fraction Assessment by Adopting Quantitative Methods. Echocardiography 33(12):1936-1937, 2016. PMID: 27917602.
24. Fadol AP, Banchs J, Hassan SA, Yeh ET, Fellman B. Withdrawal of Heart Failure Medications in Cancer Survivors With Chemotherapy-Induced Left Ventricular Dysfunction: A Pilot Study. J Card Fail 6(6):481-482, 2016. e-Pub 2016. PMID: 27036866.
25. Yusuf SW, Hassan SA, Mouhayar E, Negi SI, Banchs J, O'Gara PT. Pericardial disease: A clinical review. Expert Rev Cardiovasc Ther 14(4):525-539, 2016. e-Pub 2016. PMID: 26691443.
26. Yusuf SW, Solhpour A, Banchs J, Lopez-Mattei JC, Durand J, Iliescu C, Hassan S, Qazilbash M. Cardiac Amyloidosis. Expert Rev of Cardiovasc Therapy 12(2):265-77, 2014. e-Pub 2014.
27. Ragbir S, Jneid H, Hassan S, Bozkurt B. Hyperacute T-waves: Wolff-Parkinson White Pattern or Acute Coronary Syndrome?. J Emerg Med 44(2):332-5, 2013. e-Pub 2012. PMID: 22726664.
28. Divakaran V, Mehta S, Yao D, Hassan S, Simpson S, Wiegerinck E, Swinkels DW, Mann DL, Afshar-Kharghan V. Hepcidin in anemia of chronic heart failure. Am J Hematol 86(1):107-109, 2011. PMID: 21080339.
29. Hassan SA, Deswal A, Bozkurt B, Aguilar D, Mann DL, Pritchett AM. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail 4(7):590-595, 2008. e-Pub 2008. PMID: 18722325.
30. Ensenat D, Hassan S, Reyna SV, Schafer AI, Durante W. Transforming growth factor-beta 1 stimulates vascular smooth muscle cell L-proline transport by inducing system A amino acid transporter 2 (SAT2) gene expression. Biochem J 360(Pt 2):507-12, 2001. PMID: 11716780.

Manuals, Teaching Aids, Other Teaching Publications

1. Yeh E, Chang HM, Hassan SA. MD Anderson Practices in Onco-Cardiology Department of Cardiology at MDACC: Houston, 2016.
2. Hassan SA, Banchs J. Monitoring for Cardiotoxicity with Left Ventricular Ejection Fraction. MD Anderson Practices in Onco-Cardiology. Department of Cardiology at MDACC: Houston, 2016.

Abstracts

1. Giza D, Lopez-Mattei J, Kim P, Munoz E, Hermann J, Iliescu G, Yang E, Hassan SA, Iliescu C. Stress induced Cardiomyopathy Triggered by Chemotherapy: When Should Cancer Therapy be Restarted?. 66th ACC Annual Scientific Session, 2017.
2. Vejpongsa P, Chen M, Araujo D, Massey M, Banchs J, Acholonu S, Hassan SA, Meng W, Yeh E. Comparing the Efficacy of Primary Prevention Strategies in Doxorubicin-induced Cardiotoxicity using Echocardiography and High-Sensitivity Troponin T. Abstract presented at the American Heart Association Annual Conference, 2014.
3. Fadol A, Banchs J, Hassan SA, Durand J, Shelton V, Fellman B, Yeh E. Can Medications Be Safely Withdrawn in Patients with Chemotherapy-Induced Heart Failure with Recovered Heart Function?. Abstract presented at the Heart Failure Society of America Scientific Session 20(8, S5), 2014.
4. Iliescu C, LeBeau J, Silva G, Frusina S, Muskan A, Iliescu G, Tomakin G, Manoukian G, Banchs J, Kim P, Hassan SA, Durand J. Optical Coherence Tomography-guided anAntiplatelet Therapy in Patients with Coronary Artery Disease and Cancer. Abstract presented at the Annual Conference of American College of Cardiology, 2013.
5. Divakaran V, Mehta S, Yao D, Hassan SA, Mann D, Afshar-Kharghan V. Hepcidin does not mediate Anemia in Chronic Heart Failure Patients. Heart Failure Society of America Scientific Session, 2010.
6. Ramanathan V, Hassan SA, Thornby J, Pritchett A. Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Utilization in Hospitalized Patients with Heart Failure and Kidney Disease. American Society of Nephrology Annual Meeting, 2008.
7. Hassan SA, Deswal A, Bozkurt B, Thohan V, Mann D, Shaikh K, Pritchett A. Obesity and the Metabolic Syndrome are Associated with Improved Survival in the Heart Failure Population. ACC Scientific Sessions, Atlanta 2006, 2006.

Book Chapters

1. Chaftari P, Mouhayar E, Iliescu C, Hassan SA, Kim P. In: Cardiac Emergencies in Cancer Patients”. Oncologic Emergencies: Springer, New York, 2016.